Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Cognitive Dysfunction 1 Alzheimer Disease 1

Interventions

Specimen Handling 273 Magnetic Resonance Spectroscopy 224 pembrolizumab 214 Carboplatin 173 Biopsy 166 Cisplatin 159 Nivolumab 149 Cyclophosphamide 133 Radiotherapy 117 Paclitaxel 117 Gemcitabine 112 Bevacizumab 92 durvalumab 86 Dexamethasone 80 Rituximab 76 Oxaliplatin 73 atezolizumab 68 Capecitabine 67 venetoclax 66 Fluorouracil 66 Doxorubicin 65 Docetaxel 65 Etoposide 63 Radiosurgery 60 Radiation 57 Prednisone 57 Cytarabine 56 Ipilimumab 55 Pemetrexed 54 Taxes 52

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × fasudil × 90 days × Clear all

NCT06362707 2026-05-04

FEAD

Helse Stavanger HF

Phase 2 Recruiting

Alzheimer Disease, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡